| Original language | English |
|---|---|
| Pages (from-to) | 10-11 |
| Number of pages | 2 |
| Journal | Cell Stem Cell |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| State | Published - 7 Jan 2021 |
Bibliographical note
Funding Information:N.B. is the Herbert Cohn Chair in Cancer Research. This work was partially supported by the US-Israel Binational Science Foundation (grant no. 2015089), the Israel Science Foundation (grant no. 494/17), The Rosetrees Trust, and the Azrieli Foundation (to N.B.). Y.A. and N.B. designed the original research. K.E. supplied the reference whole-exome sequencing. Y.A. established the bioinformatical pipeline and performed the original analysis. E.L and Y.A. reanalyzed the data and revised the pipeline. Y.A. E.L. and N.B. interpreted the results and together with K.E. prepared the manuscript. N.B. supervised the study and secured funding. N.B. is CSO of NewStem Ltd. K.E. is a founder of Q-State Biosciences, Quralis, and Enclear Therapies.
Funding Information:
N.B. is the Herbert Cohn Chair in Cancer Research. This work was partially supported by the US-Israel Binational Science Foundation (grant no. 2015089 ), the Israel Science Foundation (grant no. 494/17 ), The Rosetrees Trust , and the Azrieli Foundation (to N.B.).
